According to Dr. Erick Eiting, vice chair of operations for emergency medicine at Mount Sinai Downtown in New York City, doctors are now struggling to differentiate between COVID-19, allergies, and the common cold.

Must Watch: Would you live on 3D Printed Mars for a year for $60,000?

It is becoming more and more difficult for medical experts to distinguish between Covid-19, allergies, and the usual cold.

The days when a dry cough and a loss of taste or smell were the hallmark indications of COVID-19 are long gone.

The symptoms have changed, according to Dr. Erick Eiting, vice chair of operations for emergency medicine at Mount Sinai Downtown in New York City.

“It isn’t the same typical symptoms that we were seeing before. It’s a lot of congestion, sometimes sneezing, usually a mild sore throat,” he shared with NBC News.

He said that often, a sore throat comes on first, then nasal congestion.

Eiting acknowledged that without the testing, it would have been assumed to be a simple cough or cold and that was the only reason they were able to diagnose it as COVID.

“The only way that we knew that it was Covid was because we happened to be testing them,” Eiting said.

More from Audacy News:

So, when it comes to who is being hospitalized now with symptoms being reportedly milder, the CDC says that the 80% increase in weekly average was largely contributed to by those ages 75 and up, followed by babies six months and younger and adults ages 65 to 74.

The U.S. is currently recording approximately 19,000 Covid hospitalizations per week, according to the CDC.

The CDC reported that since January, most people hospitalized for Covid had not received a bivalent booster dose of the vaccine.

Still, cases have continued to decline over the last two years, and a recent study published this month found that the drop in Covid rates began once the omicron variant became the dominant strain of the virus.

Researchers in the study shared that they did not know if milder disease contributed to the trend or if it was caused by population immunity.

This pattern has also been observed in the Zoe COVID Symptom Study (pdf below), which gathers information on self-reported symptoms in the United Kingdom. According to the study, sore throats increased in frequency when the Omicron version took over in late 2021. Conversely, the loss of scent became less common.

Data from the ZOE app, which tracks symptoms reported by people who have tested positive for SARS-CoV-2, was used in the study. The study focuses on two distinct historical periods: one during which the Omicron variant predominated and the other during which the Delta variant predominated.

According to the Food and Drug Administration, the new COVID-19 vaccine booster was tested on only eight mice.

The NIH-funded study also revealed that hospital admission rates were somewhat lower during the time when Omicron was common.

Remember that the CDC will revoke the PCR test’s emergency use license for COVID-19 testing, as The Gateway Pundit reported in December 2021. In order to “facilitate detection and differentiation” between the flu and the COVID-19 virus, the CDC recommended laboratories look into alternatives.

Via the CDC website:

In preparation for this change, CDC recommends clinical laboratories and testing sites that have been using the CDC 2019-nCoV RT-PCR assay select and begin their transition to another FDA-authorized COVID-19 test. CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses. Such assays can facilitate continued testing for both influenza and SARS-CoV-2 and can save both time and resources as we head into influenza season.

This explains why there were no more Flu cases reported in the US in 2020. Additionally, it increased the COVID cases, as was anticipated by Dr. Fauci and the DC elites.

Even the former director of the CDC, Rochelle Walensky, acknowledged this, claiming that PCR tests are inaccurate and can falsely remain positive for up to 12 weeks, therefore the testing at the conclusion of quarantine is no longer necessary.

The CDC was aware of the flawed PCR testing from the start, but they nonetheless used them to undermine the economy and remove Trump from office.

Finally, Walensky acknowledged what we have been aware of for almost two years: faulty PCR tests combined with protracted quarantine periods have resulted in a “casedemic.”

So, Walensky said on “Good Morning America” on Wednesday, “So, what we do know is the PCR test after infection can be positive for up to 12 weeks so that is not going to be helpful.”

“You’re not going to be transmitting during all of that period of time,” she said. “We’ve seen that in study after study.”

Walensky also acknowledged that the antigen test people were taking five days after contracting COVID-19 was flawed and was no longer required.

An Israeli study appears to demonstrate that persons with natural immunity are better protected against the NEW DELTA VARIANT than those who have received all of the recommended vaccinations.

The research team from Tel Aviv University and Maccabi Healthcare posted their findings on medRxiv.org.

‘This study demonstrated that natural immunity confers longer lasting and stronger protection against infection, symptomatic disease and hospitalization caused by the Delta variant of SARS-CoV-2, ‘ the team of researchers wrote

And not just marginally better. People who have received both doses of the Pfizer vaccine are 13 TIMES more likely to experience a breakthrough infection and even have a “greater risk for COVID-19 hospitalizations.”

MOST IMPORTANTLY, the study discovered that those who had received vaccinations had a 13.06 times higher risk of getting COVID three months after a second dose and a 27 times higher likelihood of exhibiting symptoms.

After adjusting for comorbidities, we found a 27.02-fold risk (95% CI, 12.7 to 57.5) for symptomatic breakthrough infection as opposed to symptomatic reinfection (P<0.001) (Table 2b). None of the covariates were significant, except for age ≥60 years. 

According to a study by researchers from the National Institutes of Health (NIH) and Moderna Inc., mRNA vaccines reduce a person’s ability to fight off infections with COVID-19 over the long run as compared to those who have not received the vaccine.

To assess anti-nucleocapsid antibody (anti-N Ab) seropositivity in Moderna vaccine efficacy following COVID-19 infection, researchers conducted a placebo-controlled vaccine efficacy trial, which was published at medRxiv.

“To evaluate for evidence of prior infection in a person with a history of COVID-19 vaccination, a test that specifically evaluates anti-N should be used. Past infection is best determined by serologic testing that indicates the presence of anti-N antibody,” according to the CDC.

During the blinded phase of the research (until March 2021) at 99 sites in the US, data from 1,789 patients with COVID-19 infection (1,298 placebo receivers and 491 vaccination recipients) were evaluated.

According to the study’s findings, patients who receive the Moderna vaccine and contract the infection may have lesser susceptibility to anti-nucleocapsid antibodies (anti-N Abs). The anti-N Ab response in unvaccinated individuals has been observed to be persistent, with half-life estimations ranging from 68 to 283 days, according to the study.

Compared to the placebo group, which received 605 out of 648 shots, only 21 out of 52 (or 40%) of the persons with proven COVID-19 disease had antibodies.

Moreover, according to a report from the Centers for Disease Control and Prevention (CDC), those who recovered from COVID-19 while unvaccinated were better protected than those who were both unvaccinated and uninfected prior to the most recent delta surge.

Between May 30 and November 20, 2021, the researchers examined data from 1.1 million adult instances of COVID-19 in California and New York (which together make up about 18% of the U.S. population).

The study found that from May to November 2021, unvaccinated people without a history of illness had the greatest case and hospitalization rates.

“Before Delta became the predominant variant in June, case rates were higher among persons who survived a previous infection than persons who were vaccinated alone. By early October, persons who survived a previous infection had lower case rates than persons who were vaccinated alone,” the study stated.

The study supported our long-held belief that “natural immunity” gained via prior COVID-19 infection is more effective than experimental vaccines.

The question of why those with inherent immunity should be obliged to receive the Covid vaccination was ultimately put to Dr. Fauci in 2021.

Dr. Sanjay Gupta, a CNN contributor, questioned Fauci on Friday over a recent Israeli study that essentially verifies that those with natural immunity are better protected against COVID than those who have received all of the recommended vaccinations.

“There was a study that came out of Israel about natural immunity and basically the headline was that natural immunity provides a lot of protection – even better than the vaccines alone,” Gupta said.

“Should they also get the vaccine? How do you make the case to [people with natural immunity]”? Gupta asked Fauci.

“You know, that’s a really good point,” Fauci said. “I don’t have a really firm answer on that.”

Why did Joe Biden announce laws requiring the vaccination of millions of Americans if natural immunity still has to be debated and studied?

Read the study given below:

GreatGameIndia is being actively targeted by powerful forces who do not wish us to survive. Your contribution, however small help us keep afloat. We accept voluntary payment for the content available for free on this website via UPI, PayPal and Bitcoin.

Support GreatGameIndia

PIIS0140673622003270





Source link

Leave a Reply

Your email address will not be published. Required fields are marked *